Location History:
- Chepstow, GB (2010)
- Tintern Gwent, GB (2013 - 2015)
- Bristol, GB (2013 - 2016)
Company Filing History:
6 out of 103 
1 out of 1 Years Active: 2010-2016
Title: Innovations of Steven J Harper
Introduction
Steven J Harper is a notable inventor based in Tintern, GB. He has made significant contributions to the field of biomedical research, particularly in the area of angiogenesis. With a total of 6 patents, Harper's work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Among his latest patents, Harper has developed methods for pro- and anti-angiogenic treatments. This invention provides a method of selectively controlling alternative splicing during the processing of VEGF pre-mRNA. By using controlling agents for splicing, the treatment can favor either proximal splice site (PSS) or distal splice site (DSS) splicing, depending on whether pro-angiogenic or anti-angiogenic effects are desired. Another significant patent involves an isolated VEGF polypeptide that exhibits anti-angiogenic activity, which includes the amino acid sequence of SEQ. ID NO. 1, or variants thereof.
Career Highlights
Harper has worked with esteemed institutions such as the University of Bristol and Philogene, Inc. His research has focused on the mechanisms of angiogenesis and the development of targeted therapies.
Collaborations
Some of his notable collaborators include David O Bates and Miriam Y Mengelus. Their combined expertise has contributed to the advancement of Harper's innovative research.
Conclusion
Steven J Harper's contributions to the field of angiogenesis through his patents and collaborations highlight his role as a significant inventor in biomedical research. His work continues to pave the way for new therapeutic approaches.